专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

GB0319715D0 Treatment of auto-inflammatory disease 未知
公开(公告)号：GB0319715D0
公开(公告)日：2003-09-24
申请号：GB0319715
申请日：2003-08-21
申请人： CAREY NORMAN H , ADAMSON PETER

2. 发明申请

WO2013079696A1 METHODS OF TREATMENT AND PREVENTION OF EYE DISEASES 审中-公开
标题翻译：治疗和预防眼病的方法
公开(公告)号：WO2013079696A1
公开(公告)日：2013-06-06
申请号：PCT/EP2012/074156
申请日：2012-11-30
申请人： GLAXO GROUP LIMITED , ADAMSON, Peter , SHIMA, David , NG, Yin, Shan, Eric
发明人： ADAMSON, Peter , SHIMA, David , NG, Yin, Shan, Eric
IPC分类号： A61K31/395 , A61K31/5375 , A61P27/02
CPC分类号： C07D295/145 , A61K31/395 , A61K31/5375 , A61K45/06 , A61K2300/00
摘要： The present invention provides compositions and methods useful for treating and preventing neovascular AMD by inhibition of CCR3. The compositions and methods are useful for treating and preventing diseases and disorders such as but not limited to, neovascular AMD.
摘要翻译：本发明提供了通过抑制CCR3来治疗和预防新生血管性AMD的组合物和方法。组合物和方法可用于治疗和预防疾病和病症，例如但不限于新生血管性AMD。

3. 发明申请

WO2010048674A1 A DEVICE FOR PICKING UP AND TRANSPORTING A LOAD 审中-公开
标题翻译：用于拾取和运输货物的装置
公开(公告)号：WO2010048674A1
公开(公告)日：2010-05-06
申请号：PCT/AU2009/001419
申请日：2009-10-29
申请人： STRANG INTERNATIONAL PTY LTD , ADAMSON, Peter, Robert , ALLEN, Lyal, Douglas , STRANG, Andrew, John, Donald
发明人： ADAMSON, Peter, Robert , ALLEN, Lyal, Douglas , STRANG, Andrew, John, Donald
IPC分类号： B60P3/00 , B62D21/14 , B62D63/06 , B60P1/00 , B62D21/20 , B66F9/06 , B60P1/02 , B62D53/06
CPC分类号： B62D21/20 , B60P1/025 , B60S9/215 , B62D21/14 , B62D63/068 , B66C19/005
摘要： A trailer (10) for picking up and transporting a load (200) includes a pair of chassis sides (12, 14) each chassis side including wheels (110) supporting the trailer, and a protrusion (150) for engaging with a load to be picked up and transported. The trailer also includes a cruciform link mechanism (36, 38) for expanding and contracting the trailer by moving the chassis sides (12, 14) towards and away from each other. This enables the device to be positioned on either side of a load (200) in an expanded state and subsequently contracted to engage with the load. The cruciform link mechanism (36, 38) is located above the load in use and comprises two link members (36, 38) of substantially equal length which are pivoted to each other at their respective centres (58) where they cross and which link the chassis sides together.
摘要翻译：用于拾取和运送负载（200）的拖车（10）包括一对底盘侧（12,14），每个底盘侧包括支撑拖车的轮（110）和用于与负载接合的突起（150）被拾起和运输。拖车还包括十字形连杆机构（36,38），用于通过使底盘侧面（12,14）朝向和远离彼此移动来使拖车伸缩。这使得设备能够在膨胀状态下定位在负载（200）的任一侧上，并随后收缩以与负载接合。十字形连杆机构（36,38）位于使用中的负载上方，并且包括两个大致相等长度的连杆构件（36,38），它们在它们各自的中心（58）处彼此枢转，在这些中心处，底盘两侧在一起。

4. 发明申请

WO0181551A9 RETINAL CELL LINES WITH EXTENDED LIFE-SPAN AND THEIR APPLICATIONS 审中-公开
标题翻译：具有延长生命期的细胞系及其应用
公开(公告)号：WO0181551A9
公开(公告)日：2002-08-15
申请号：PCT/IB0100860
申请日：2001-04-27
申请人： NEUROTECH SA , GREENWOOD JOHN , ADAMSON PETER , LUND RAYMOND
发明人： GREENWOOD JOHN , ADAMSON PETER , LUND RAYMOND
IPC分类号： C12N15/09 , A61K35/12 , A61K35/44 , A61P27/02 , A61P29/00 , A61P35/00 , C12N5/071 , C12N5/10 , C12P21/02 , C12N5/06 , A61K48/00 , C12N5/08
CPC分类号： C12N5/0621 , A61K35/12 , C12N2503/00 , C12N2510/02 , C12N2510/04
摘要： The invention features retina-derived (retinal endothelial or retinal epithelial pigment) cell lines with extended life-span and capable of being implanted in the retina and of carrying a therapeutic substance to the eye and to the central nervous system. Such lines can also be used as a model for studying blood central nervous system interfaces. These lines are derived from primary retinal cultures selected from the group consisting of primary retinal endothelial cells and primary retinal epithelial cells, comprise a polynucleotide containing an oncogene, which polynucleotide is optionally associated with at least one selection gene, and have the morphological characteristics and at least the expression characteristics of the surface antigens of corresponding primary cultures.
摘要翻译：本发明特征在于视网膜衍生（视网膜内皮或视网膜上皮细胞色素）细胞系具有延长的寿命并且能够植入视网膜并且将治疗物质携带到眼睛和中枢神经系统。这样的线也可以用作研究血液中枢神经系统界面的模型。这些系衍生自选自原发性视网膜内皮细胞和原代视网膜上皮细胞的原代视网膜培养物，包含含有癌基因的多核苷酸，所述多核苷酸任选地与至少一个选择基因相关，并具有形态特征最小表达相关原代培养物的表面抗原特征。

5. 发明申请

WO2012080497A3 USE OF LP-PLA2 INHIBITORS IN THE TREATMENT AND PREVENTION OF EYE DISEASES 审中-公开
标题翻译： LP-PLA2抑制剂在治疗和预防眼疾中的应用
公开(公告)号：WO2012080497A3
公开(公告)日：2012-08-23
申请号：PCT/EP2011073121
申请日：2011-12-16
申请人： GLAXO GROUP LTD , ADAMSON PETER , LEE DANIEL
发明人： ADAMSON PETER , LEE DANIEL
IPC分类号： A61K31/00 , A61K31/135 , A61K31/517 , A61K31/7088 , A61P27/02
CPC分类号： A61K31/513 , A61K31/00 , A61K31/135 , A61K31/496 , A61K31/517 , A61K31/7088
摘要： The present invention provides compositions and methods useful for treating and preventing ocular diseases by inhibition of Lp-PLA2. The compositions and methods are useful for treating and preventing diseases and disorders such as but not limited to, macular edema, uveitis and diabetic retinopathy.
摘要翻译：本发明提供了用于通过抑制Lp-PLA2治疗和预防眼部疾病的组合物和方法。组合物和方法可用于治疗和预防疾病和病症，例如但不限于黄斑水肿，葡萄膜炎和糖尿病性视网膜病变。

6. 发明申请

WO1990003312A1 BUNDLE STRAP INSTALLATION APPARATUS 审中-公开
标题翻译： BUNDLE STRAP安装设备
公开(公告)号：WO1990003312A1
公开(公告)日：1990-04-05
申请号：PCT/AU1989000420
申请日：1989-09-29
申请人： STRANG INTERNATIONAL PTY LIMITED , ADAMSON, Peter, Robert , BALDOCK, Kenneth, William , TAYLOR, Lindley, Alan
发明人： STRANG INTERNATIONAL PTY LIMITED
IPC分类号： B65B13/18
CPC分类号： B65B13/18
摘要： A bundle strap installation apparatus (10) to facilitate the strapping of units of bundles (7) according to USLM (Unit Strap Lifting Method) practice. The apparatus (10) comprising a plurality of trolleys (14) which are movable from a compact condition for receiving a unit of bundles (7), to a spread condition in which the bundles (7) of the unit are spread apart to form sub-units (6) to thereby allow respective straps (8) to be placed on the bundles (7). The apparatus (10) further comprises means (16) to move the trolleys (14) from the compact condition to the spread condition and means (18) to temporarily lift the bundles (7) off the trolleys (14) to facilitate positioning of the straps (8) about the bundles (7).
摘要翻译：捆绑带安装装置（10），用于根据USLM（单元吊带提升方法）实践来捆绑束（7）的单元捆扎。所述装置（10）包括多个手推车（14），所述多个手推车（14）可从用于接收捆束（7）的单元的紧凑状态移动到扩展状态，其中所述装置的捆（7）分开形成子（6），从而允许将各个带（8）放置在束（7）上。装置（10）还包括用于将手推车（14）从紧凑状态移动到展开状态的装置（16）和装置（18）以将捆（7）临时提升离开手推车（14），以便于定位关于束（7）的带（8）。

7. 发明申请

WO2016106056A1 REPROGRAMMING A PORT CONTROLLER VIA ITS OWN EXTERNAL PORT 审中-公开
标题翻译：通过其外部端口汇报端口控制器
公开(公告)号：WO2016106056A1
公开(公告)日：2016-06-30
申请号：PCT/US2015/066231
申请日：2015-12-17
申请人： INTEL CORPORATION , TRETHEWEY, James R. , ADAMSON, Peter S. , VALAVI, John J. , NARAYANAN, Anantha , PALANISAMY, Kandasubramaniam K. , SAAD, Ihab W.
发明人： TRETHEWEY, James R. , ADAMSON, Peter S. , VALAVI, John J. , NARAYANAN, Anantha , PALANISAMY, Kandasubramaniam K. , SAAD, Ihab W.
IPC分类号： G06F11/22 , G01R31/317
CPC分类号： G01R31/3177 , G01R31/31705 , G06F11/2236 , G06F11/26 , G06F11/36 , G06F11/3656
摘要： Systems and methods may provide for a debug tool including a debug port and a controller including logic to send, via the debug port, a debug mode request to an external port of a target device. Additionally, the target device may include a connector having the external port and a port controller coupled to the external port, wherein the port controller includes logic to detect the debug mode request via the external port, activate a program path between the external port and the port controller in response to the debug mode request, and process one or more commands received via the program path. In one example, the target device further includes a multiplexer coupled to the external port and the port controller, wherein the logic is to send a routing signal to the multiplexer to activate the program path.
摘要翻译：系统和方法可以提供包括调试端口和控制器的调试工具，该调试端口和控制器包括经由调试端口将调试模式请求发送到目标设备的外部端口的逻辑。此外，目标设备可以包括具有外部端口的连接器和耦合到外部端口的端口控制器，其中端口控制器包括经由外部端口检测调试模式请求的逻辑，激活外部端口与外部端口之间的程序路径端口控制器响应于调试模式请求，并处理经由程序路径接收的一个或多个命令。在一个示例中，目标设备还包括耦合到外部端口和端口控制器的多路复用器，其中逻辑是将路由信号发送到多路复用器以激活程序路径。

8. 发明申请

WO2010136492A3 COMBINATION OF A TNF-ALPHA ANTAGONIST AND A VEGF ANTAGONIST FOR USE IN THE TREATMENT OR PREVENTION OF DISEASES OF THE EYE. 审中-公开
公开(公告)号：WO2010136492A3
公开(公告)日：2010-12-02
申请号：PCT/EP2010/057246
申请日：2010-05-26
申请人： GLAXO GROUP LIMITED , ADAMSON, Peter , ERTL, Peter, Franz , GERMASCHEWSKI, Volker , GOUGH, Gerald, Wayne , STEWARD, Michael
发明人： ADAMSON, Peter , ERTL, Peter, Franz , GERMASCHEWSKI, Volker , GOUGH, Gerald, Wayne , STEWARD, Michael
IPC分类号： A61K39/395 , C07K16/22 , C07K16/24 , A61P27/02 , C07K14/715
摘要： Combinations of TNF&alpha,- antagonists with VEGF antagonists for use in treating diseases of the eye, and provides antigen-binding proteins which bind to TNFα or a TNFα receptor and/or VEGF or a VEGF receptor.

9. 发明申请

WO2010136492A2 ANTIGEN-BINDING PROTEINS 审中-公开
标题翻译：抗原结合蛋白
公开(公告)号：WO2010136492A2
公开(公告)日：2010-12-02
申请号：PCT/EP2010057246
申请日：2010-05-26
申请人： GLAXO GROUP LTD , ADAMSON PETER , ERTL PETER FRANZ , GERMASCHEWSKI VOLKER , GOUGH GERALD WAYNE , STEWARD MICHAEL
发明人： ADAMSON PETER , ERTL PETER FRANZ , GERMASCHEWSKI VOLKER , GOUGH GERALD WAYNE , STEWARD MICHAEL
IPC分类号： A61K39/395 , A61P27/02 , C07K14/715 , C07K16/22 , C07K16/24
CPC分类号： C07K16/241 , A61K39/3955 , A61K2039/507 , C07K16/22 , C07K2317/21 , C07K2317/56 , C07K2317/569 , C07K2319/00 , A61K2300/00
摘要： The invention relates to combinations of TNFa antagonists with VEGF antagonists for use in treating diseases of the eye, and provides antigen-binding proteins which bind to TNFa or a TNFa receptor and/or VEGF or a VEGF receptor.
摘要翻译：本发明涉及TNFα拮抗剂与用于治疗眼睛疾病的VEGF拮抗剂的组合，并提供结合TNFα或TNFα受体和/或VEGF或VEGF受体的抗原结合蛋白。

10. 发明申请

WO0181551A8 RETINAL PIGMENT EPITHELIAL CELL LINES WITH EXTENDED LIFE-SPAN AND THEIR APPLICATIONS 审中-公开
标题翻译：具有延长寿命的后色素上皮细胞系及其应用
公开(公告)号：WO0181551A8
公开(公告)日：2003-01-03
申请号：PCT/IB0100860
申请日：2001-04-27
申请人： NEUROTECH SA , GREENWOOD JOHN , ADAMSON PETER , LUND RAYMOND
发明人： GREENWOOD JOHN , ADAMSON PETER , LUND RAYMOND
IPC分类号： C12N15/09 , A61K35/12 , A61K35/44 , A61P27/02 , A61P29/00 , A61P35/00 , C12N5/071 , C12N5/10 , C12P21/02 , C12N5/06 , A61K48/00 , C12N5/08
CPC分类号： C12N5/0621 , A61K35/12 , C12N2503/00 , C12N2510/02 , C12N2510/04
摘要： The invention features retina-derived (retinal endothelial or retinal epithelial pigment) cell lines with extended life-span and capable of being implanted in the retina and of carrying a therapeutic substance to the eye and to the central nervous system. Such lines can also be used as a model for studying blood central nervous system interfaces. These lines are derived from primary retinal cultures selected from the group consisting of primary retinal endothelial cells and primary retinal epithelial cells, comprise a polynucleotide containing an oncogene, which polynucleotide is optionally associated with at least one selection gene, and have the morphological characteristics and at least the expression characteristics of the surface antigens of corresponding primary cultures.
摘要翻译：本发明特征在于视网膜衍生（视网膜内皮或视网膜上皮细胞色素）细胞系具有延长的寿命并且能够植入视网膜并且将治疗物质携带到眼睛和中枢神经系统。这样的线也可以用作研究血液中枢神经系统界面的模型。这些系衍生自选自原发性视网膜内皮细胞和原代视网膜上皮细胞的原代视网膜培养物，包含含有癌基因的多核苷酸，所述多核苷酸任选地与至少一个选择基因相关，并具有形态特征最小表达相关原代培养物的表面抗原特征。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式